Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR) γ activators
Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR) γ activators
批准号:
13671105
负责人:
HARAGUCHI Kazutaka
金额:
$1.79万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
最近有报道称过氧化物酶体增殖物激活受体(PPAR) γ具有抗炎作用。一些报道表明PPAR γ对肾细胞有影响,但确切的知识有限。首先,我们检测了PPARg激活剂对克隆肾细胞(LLC-PK1)凋亡的影响,RT-PCR显示了PPARg在LLC-PK1细胞中的表达。ppar配体如曲格列酮、BRL49653和15-脱氧- δ -12,14-前列腺素J2抑制血清剥夺诱导的细胞凋亡。PPARa激活剂没有模仿曲格列酮的效果。曲格列酮的抗凋亡作用可被磷脂酰肌醇-3激酶(PI3K)抑制剂wortmannin部分阻断,而其他激酶抑制剂则不能。此外,我们发现曲格列酮增加了c-myc的表达,据报道,在其他系统中,c-myc在缺乏血清的情况下会导致细胞凋亡。而bcl-2的表达不受影响。这些结果表明,PPARg的激活对lc - pk1细胞通过PI3K途径被剥夺血清诱导的细胞凋亡具有抑制作用。注射兔抗大鼠肾小球基底膜抗体诱导WKY大鼠继发性月牙状肾小球肾炎。曲格列酮可抑制尿蛋白排泄和新月形成,如新月评分所示。吡格列酮的作用类似于曲格列酮,而PPAR α-活化剂则没有。免疫组织学显示,曲格列酮和吡格列酮抑制ed -1阳性单核/巨噬细胞和cd8阳性细胞向肾小球的浸润。在本研究中,我们证明了PPAR γ激活剂通过PPAR依赖机制抑制炎症细胞的募集来发挥抗肾病作用。综上所述,在肾细胞中,PPARγ-激活剂可抑制体外培养的肾细胞凋亡并抑制实验性大鼠肾小球肾炎,PPARγ-依赖性机制可能在肾细胞中起重要作用。少
英文摘要
It has been recently reported that peroxisome proliferator-activated receptor (PPAR) γ exhibits anti-inflammatory effects. A couple of reports suggests effects of PPAR γon kidney cells, but precise knowledge are limited.First, we examined the effects of PPARg activators on the apoptosis of clonal kidney cells (LLC-PK1), RT-PCR revealed the expression of PPARg in LLC-PK1 cells. The ligands for PPARg such as troglitazone, BRL49653 and 15-deoxy-delta-12,14-prostaglandin J2 inhibited serum-deprivation-induced apoptosis of the cells. PPARa activators did not mimic the effect of troglitazone. Antiapoptotic effects of troglitazone were partially blocked by a phosphatidyl-inositol-3 kinase (PI3K) inhibitor, wortmannin, but not by other kinase inhibitors. Further, we showed that troglitazone increased the expression of c-myc which was reported to cause apoptosis in the absence of serum in other systems. However, the expression of bcl-2 was not affected. These results suggest that the activation … More of PPARg has an inhibitory effect on the apoptosis induced by serum deprivation through the PI3K pathway in LLC-PK1 cells.Secondary, crescentic glomerulonephritis was induced by the injection of rabbit anti-rat glomerular basement membrane antibody in WKY rats. Administration of troglitazone suppressed urinary protein excretion and crescent formation as indicated by crescent scores. Pioglitazone mimicked the effect of troglitazone, but PPAR α-activators did not. Immunohistology revealed that troglitazone and pioglitazone inhibited the infiltration of ED-1-positive monocyte/macrophages and CD8-positive cells into glomeruli. In the present study, we demonstrated that PPAR γ activators exert antinephritic effects by suppressing the recruitment of inflammatory cells via PPARg-dependent mechanism.In conclusion, in kidney cells, PPAR γ-activators inhibits apoptosis of cultured kidney cells in vitro and suppresses experimental glomerulonephritis in rats, PPARγ-dependent mechanism may have a important role in kidney cells. Less
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Haraguchi Kazutaka: "Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR) γ activators"Clin Exp Nephrol. 7. 27-32 (2003)
Haraguchi Kazutaka:“通过过氧化物酶体增殖物激活受体(PPAR)γ激活剂抑制实验性新月体肾小球肾炎”Clin Exp Nephrol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Haraguchi Kazutaka: "Activation of Peroxisome proliferator-activated receptor-g inhibits apoptosis induced by serum deprivation in LLC-PK1 Cells"Exp Nephrol. 10. 393-401 (2002)
Haraguchi Kazutaka:“过氧化物酶体增殖物激活受体-g 的激活抑制 LLC-PK1 细胞中血清剥夺诱导的细胞凋亡”Exp Nephrol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Haraguchi Kazutaka: "Suppression of experimental crescentic glomerulonephritis by peroxisome proliferator-activated receptor (PPAR)γ activators"Clin Exp Nephrol. 7. 27-32 (2003)
Haraguchi Kazutaka:“通过过氧化物酶体增殖物激活受体(PPAR)γ激活剂抑制实验性新月体肾小球肾炎”Clin Exp Nephrol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Haraguchi Kazutaka: "Suppression of experimental crescentic glomerulonephritis by peroxisome probiferator-astivated receptor (PPAR)γ activators"Clin Exp Nephrol. 7. 27-32 (2003)
Haraguchi Kazutaka:“过氧化物酶体激活受体(PPAR)γ激活剂抑制实验性新月体肾小球肾炎”Clin Exp Nephrol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Haraguchi Kazutaka: "Activation of peroxisome proliferator-activated receptor γ inhibits apoptosis induced by serum deprivation in LLC-PK1 cells"Exp Nephrol. 10. 393-401 (2002)
Haraguchi Kazutaka:“过氧化物酶体增殖物激活受体 γ 的激活抑制 LLC-PK1 细胞中血清剥夺诱导的细胞凋亡”Exp Nephrol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 7 条
Molecular Mechanisms of Expression of TSHR and Graves' Ophthaolmopathy
-
批准号:10671032
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:1998
-
负责人:HARAGUCHI Kazutaka
-
依托单位:
Study on the Pathogenesis of Graves' Ophthalmopathy using 3T3-L1 Cells Which Express Thyrotropin Receptor
-
批准号:08671143
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.47万
-
财政年份:1996
-
负责人:HARAGUCHI Kazutaka
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: